![Pharmaceuticals | Free Full-Text | Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets Pharmaceuticals | Free Full-Text | Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00539/article_deploy/html/images/pharmaceuticals-16-00539-g001.png)
Pharmaceuticals | Free Full-Text | Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets
![Pharmaceuticals | Free Full-Text | Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets Pharmaceuticals | Free Full-Text | Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-16-00539/article_deploy/html/images/pharmaceuticals-16-00539-ag.png?1680596860)
Pharmaceuticals | Free Full-Text | Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets
![Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands | ACS Chemical Neuroscience Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.3c00074/asset/images/medium/cn3c00074_0010.gif)
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands | ACS Chemical Neuroscience
![Stocks To Watch: Teva Pharmaceutical ADR Sees Relative Strength Rating Jump To 81 | Investor's Business Daily Stocks To Watch: Teva Pharmaceutical ADR Sees Relative Strength Rating Jump To 81 | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
Stocks To Watch: Teva Pharmaceutical ADR Sees Relative Strength Rating Jump To 81 | Investor's Business Daily
![Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment | NEJM Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.351.issue-6/nejmoa033513/production/images/img_medium/nejmoa033513_f1.jpeg)
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment | NEJM
![Recent advances and clinical translation of liposomal delivery systems in cancer therapy - ScienceDirect Recent advances and clinical translation of liposomal delivery systems in cancer therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0928098723003160-gr9.jpg)
Recent advances and clinical translation of liposomal delivery systems in cancer therapy - ScienceDirect
![Molecules | Free Full-Text | Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study Molecules | Free Full-Text | Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study](https://pub.mdpi-res.com/molecules/molecules-25-00537/article_deploy/html/images/molecules-25-00537-ag.png?1582224581)
Molecules | Free Full-Text | Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study
![Teva- Pharmaceutical Industries Ltd. - ADR Shares Climb 0.2% Past Previous 52-Week High - Market Mover | Nasdaq Teva- Pharmaceutical Industries Ltd. - ADR Shares Climb 0.2% Past Previous 52-Week High - Market Mover | Nasdaq](https://www.nasdaq.com/sites/acquia.prod/files/kwhen/TEVA-eeea86bc-f154-420e-abfb-bae276279f90.png)
Teva- Pharmaceutical Industries Ltd. - ADR Shares Climb 0.2% Past Previous 52-Week High - Market Mover | Nasdaq
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth | Journal of Medicinal Chemistry
![Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review](https://html.scirp.org/file/3-2151426x2.png?20211009092125135)